Prospective Non-interventional Study of Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
Conditions: Melanoma; Melanoma (Skin); Melanoma, Uveal; Melanoma Stage IV; Melanoma Stage III; Melanoma, Stage II; Melanoma in Situ; Melanoma, Ocular Intervention: Drug: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines Sponsor: MelanomaPRO, Russia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials
Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
Conditions: Melanoma (Skin); Melanoma, Uveal Intervention: Drug: Tebentafusp Sponsors: University of Oxford; Immunocore Ltd; Natera, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials